EBOS Group Stock

EBOS Group Financial Leverage

The Financial Leverage (Equity Multiplier) of EBOS Group (EBO.NZ) as of Aug 10, 2026 is 2.66. In the previous year, Financial Leverage (Equity Multiplier) was 2.75 — a change of -3.45% (lower).

Financial Leverage

2.66

YoY

-3.45%

Last updated:

Financial Leverage (Equity Multiplier) of EBOS Group is 2026 2.66 . Financial Leverage (Equity Multiplier) of EBOS Group was 2025 2.75 . It decreases by -3.45% lower compared to the previous year.
Access this data via the Eulerpool API

EBOS Group Stock analysis

What does EBOS Group do? The EBOS Group was founded in New Zealand in 2000 and has since grown to become one of the largest healthcare companies in the region. The company's business model is to provide solutions for the healthcare industry, ranging from products for pharmacies, hospitals, and medical practices to healthcare services. The company is divided into several divisions, including healthcare distribution, dental, and healthcare services. The healthcare distribution division focuses on distributing pharmaceutical products, medical devices, and other healthcare items to healthcare facilities. This includes surgical instruments and oncology products. The dental division specializes in selling and distributing dental products, such as instruments for dentists and consumables like gloves, implants, and floss. They also offer services for dentists, including a dental practice built in partnership with another company. The healthcare services division includes the distribution of home care and healthcare products, as well as the rental of medical equipment like wheelchairs and beds. EBOS Group also provides services such as consultation and training for patients, caregivers, and healthcare providers. With a strong emphasis on quality and customer satisfaction, EBOS Group has a successful track record and has acquired and developed several companies in the region. Their products help improve patient health and contribute to reducing healthcare costs. The company plays a vital role in the healthcare products and services market. The EBOS Group's diverse divisions and wide range of products secure its position as an important player in the healthcare industry. EBOS Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EBOS Group stock

Financial Leverage (Equity Multiplier) of EBOS Group is 2.66 in 2026.

Financial Leverage (Equity Multiplier) of EBOS Group changed from 2.75 to 2.66, representing a -3.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) EBOS Group since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s EBOS Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — EBOS Group

All Key Metrics — EBOS Group